landosbiopharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Crawl-delay: | ||
Meta Tags
| Title | Identifying Novel Pathways at the Interface of Immunity and Metabolism - Landos |
| Description | --> Skip Navigation Search: Submit Search Toggle Search Landos Biopharma on Twitter Toggle Navigation Search: About Us Our Story Management Team Board |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 172.67.182.80 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
landosbiopharma.com Valuation
|
US$26,695,680
Last updated: 2023-04-29 00:47:44
landosbiopharma.com has Semrush global rank of 396,480. landosbiopharma.com has an estimated worth of US$ 26,695,680, based on its estimated Ads revenue. landosbiopharma.com receives approximately 3,080,271 unique visitors each day. Its web server is located in United States, with IP address 172.67.182.80. According to SiteAdvisor, landosbiopharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$26,695,680 |
| Daily Ads Revenue | US$24,643 |
| Monthly Ads Revenue | US$739,265 |
| Yearly Ads Revenue | US$8,871,180 |
| Daily Unique Visitors | 205,352 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| landosbiopharma.com. | A | 299 | IP: 172.67.182.80 |
| landosbiopharma.com. | A | 299 | IP: 104.21.18.141 |
| landosbiopharma.com. | AAAA | 299 | IPV6: 2606:4700:3033::ac43:b650 |
| landosbiopharma.com. | AAAA | 299 | IPV6: 2606:4700:3037::6815:128d |
| landosbiopharma.com. | NS | 86400 | NS Record: dion.ns.cloudflare.com. |
| landosbiopharma.com. | NS | 86400 | NS Record: jean.ns.cloudflare.com. |
| landosbiopharma.com. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
| landosbiopharma.com. | MX | 300 | MX Record: 10 alt3.aspmx.l.google.com. |
| landosbiopharma.com. | MX | 300 | MX Record: 5 alt2.aspmx.l.google.com. |
| landosbiopharma.com. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
| landosbiopharma.com. | MX | 300 | MX Record: 10 alt4.aspmx.l.google.com. |
| landosbiopharma.com. | TXT | 300 | TXT Record: google-site-verification=RXzcc597OL5EYEKgwg1Fj3j-U6paFBbLsXq_abSd_tM |
| landosbiopharma.com. | TXT | 300 | TXT Record: v=DMARC1; p=none; rua=mailto:it@landosbiopharma.com |
| landosbiopharma.com. | TXT | 300 | TXT Record: MS=ms92237110 |
| landosbiopharma.com. | TXT | 300 | TXT Record: v=spf1 include:_spf.google.com ~all |
| landosbiopharma.com. | TXT | 300 | TXT Record: MS=ms30775451 |
HtmlToTextCheckTime:2023-04-29 00:47:44
| --> Skip Navigation Search: Submit Search Toggle Search Landos Biopharma on Twitter Toggle Navigation Search: About Us Our Story Management Team Board of Directors Scientific & Steering Committee Contact Us Product Candidates NX-13 Preclinical Candidates Clinical Trials Science Immuno – metabolic Pathways Discovery Platform Publications Investors/Media Investor/Media Home Press Releases Events & Presentations Analyst Coverage Stock Information SEC Filings Corporate Governance Investors/Media FAQS Careers Why Landos? Open Positions Identifying Novel Pathways at the Interface of Immunity and Metabolism shield-2 Home Illustration NX-13 NX-13 is an oral NLRX1 agonist for the treatment of Ulcerative Colitis and Crohn’s Disease. NX-13’s bimodal mechanism of action aims to decrease reactive oxygen species and oxidative stress, while decreasing pro-inflammatory signals. Next tab We are committed to the development of first-in-class, oral therapeutics for patients with autoimmune disease |
HTTP Headers
HTTP/1.1 406 Not Acceptable
Date: Thu, 21 Oct 2021 22:40:39 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=k85cZ8j5kpc%2BeBXUYlEZMiu54EmqIP3Q7USXdLKUONhayRwFRpdwD6gRIIO0%2FMGIgHIpeLLIwJV6cEscKw7EV29QrlA%2B%2Bu%2FxzQwN6KSoRceFdtjG%2Fl%2FxL3RQpVqb1JFWQnovEavm"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a1dfd28f875e1fa-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
landosbiopharma.com Whois Information
Domain Name: LANDOSBIOPHARMA.COM Registry Domain ID: 2057839219_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-09-08T12:46:20Z Creation Date: 2016-09-07T15:32:58Z Registry Expiry Date: 2022-09-07T15:32:58Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DION.NS.CLOUDFLARE.COM Name Server: JEAN.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T17:38:22Z <<< |